Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A randomized, blinded, comparator-controlled trial investigating a 28-day course of Lyrica in participants with knee osteoarthritis who exhibit neuropathic pain, compared with a 28-day course of acetaminophen.

Next Previous
X
Search
Trial Profile

A randomized, blinded, comparator-controlled trial investigating a 28-day course of Lyrica in participants with knee osteoarthritis who exhibit neuropathic pain, compared with a 28-day course of acetaminophen.

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Jul 2017

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Pregabalin (Primary) ; Paracetamol
  • Indications Neuropathic pain
  • Focus Therapeutic Use

    • Most Recent Events

    • 17 Jun 2017 Primary endpoints of WOMAC Pain scores and PainDETECT scores has been met, according to results presented at the 18th Annual Congress of the European League.
    • 17 Jun 2017 Primary endpoint of pressure pain thresholds has been met, according to results presented at the 18th Annual Congress of the European League Against Rheumatism.
    • 17 Jun 2017 Primary endpoint of cold pain thresholds has not been met, according to results presented at the 18th Annual Congress of the European League Against Rheumatism.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top